Rankings
▼
Calendar
BEAM Q2 2022 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
+277433.3% YoY
Gross Profit
-$58M
-347.7% margin
Operating Income
-$82M
-492.2% margin
Net Income
-$72M
-432.1% margin
EPS (Diluted)
$-0.69
QoQ Revenue Growth
+97.5%
Cash Flow
Operating Cash Flow
-$52M
Free Cash Flow
-$74M
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$1.4B
Total Liabilities
$618M
Stockholders' Equity
$800M
Cash & Equivalents
$266M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$6,000
+277433.3%
Gross Profit
-$58M
-$46M
-27.1%
Operating Income
-$82M
-$59M
-39.0%
Net Income
-$72M
-$76M
+5.6%
← FY 2022
All Quarters
Q3 2022 →